ATRC
AtriCure Inc
58.40$
-3.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +8.4% | +2.2% | +6.8% | -0.3% | +7.2% | -0.5% | +10.1% | -1.4% | +4.6% | +0.5% | +8.7% | – | |
| – | +12.5% | +3.1% | +6.6% | -3.5% | +8.7% | -2.1% | +11.8% | -5.0% | +9.1% | -11.1% | +9.5% | – | |
| – | +7.1% | +1.8% | +6.9% | +0.8% | +6.7% | +0.0% | +9.6% | -0.1% | +3.2% | +4.5% | +8.5% | – | |
| – | +2.2% | -4.6% | -1.0% | +6.6% | +66.8% | -35.6% | +30.0% | -21.8% | -0.6% | +6.6% | +8.9% | – | |
| – | +9.9% | +6.9% | +1.7% | -0.5% | -1.4% | +5.4% | +3.1% | -0.2% | +0.1% | +7.9% | -2.4% | – | |
| – | +7.1% | +4.2% | +2.0% | +1.0% | +13.7% | -8.0% | +9.2% | -6.1% | 0.0% | +7.6% | +0.2% | – | |
| – | – | – | – | – | – | – | – | – | +1,578.4% | -84.9% | +1,737.5% | – | |
| – | +1.5% | -6.7% | -3.9% | +3.4% | -13.0% | -2.4% | +5.2% | +95.0% | -48.2% | -10.9% | -1.6% | – | |
| – | – | – | – | – | – | – | – | – | – | -83.3% | +2,292.4% | – | |
| – | +693.6% | -50.9% | +38.3% | +27.3% | -17.4% | -10.2% | +9.2% | -30.7% | +233.7% | -52.6% | +64.7% | – | |
| – | – | – | – | – | – | – | – | – | – | -93.8% | +8,191.7% | – | |
| – | – | – | – | – | – | – | – | +991.4% | +12.3% | -21.9% | -54.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.